Task: Answer the multiple choice question.
Query: Which drug exhibits a -12.238% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a) O=C(CCCOc1ccccc1)N1CCN(S(=O)(=O)c2cccs2)CC1
b) COCCCNC(=O)/C=C/c1ccc(Cl)cc1Cl
c) CCN(Cc1nc2ccccc2c(=O)[nH]1)C(=O)CN1C(=O)NC2(CCCCC2C)C1=O
d) Cc1cccc(C)c1N1CCc2cn[nH]c21
Answer: b. COCCCNC(=O)/C=C/c1ccc(Cl)cc1Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COCCCNC(=O)/C=C/c1ccc(Cl)cc1Cl
COCCCNC(=O)/C=C/c1ccc(Cl)cc1Cl
(E)-3-(2,4-dichlorophenyl)-N-(3-methoxypropyl)prop-2-enamide